Skip to main navigation Skip to search Skip to main content

Efficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.

Translated title of the contribution: Efficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.
  • S. Rodenhuis
  • , M. Bontenbal
  • , Q.G.C.M. Van Hoesel
  • , W.M. Smit
  • , M.A. Nooij
  • , E.E. Voest
  • , E. van der Wall
  • , P.S Hupperets
  • , H. van Tinteren
  • , J.L. Peterse
  • , M.J. van de Vijver
  • , E.G. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEfficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.
Original languageUndefined/Unknown
Pages (from-to)588-596
Number of pages9
JournalAnnals of Oncology
Volume17
Issue number4
Publication statusPublished - 2006

Cite this